跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,645 条关于
“CD30 ligand”
全部
2,645
临床试验
1,314
药物
775
机构
21
资讯
535
10个月前
Merck Assumes Full Control of MK-8690 Anti-CD30 Ligand Antibody for Inflammatory Bowel Disease
去年
Novel CAR-T Cell Therapy Shows 100% Response Rate in Refractory CD30+ Lymphoma Patients
去年
Targeting CD30 in Diffuse Large B-Cell Lymphoma: Where Does It Fit in?
去年
Newcastle University Researchers Identify Novel CD30-Targeting Combination Therapy to Overcome Immune Checkpoint Blockade Resistance in Melanoma
去年
Frexalimab Shows Promise in Treating Autoimmune Diseases by Targeting CD40 Ligand
上个月
Ligand Reports 32% Royalty Revenue Growth, Raises EPS Guidance Following XOMA Acquisition
3个月前
Dual-Ligand Mitochondria-Targeted Nanosystem Achieves 85.23% Tumor Suppression in Hepatocellular Carcinoma
8个月前
€60 Million LIGAND-AI Consortium Launches to Accelerate Drug Discovery Through Open AI Datasets
3个月前
CHEPA Regimen Achieves 76% Complete Metabolic Response in CD30-Positive PTCL: Phase 2 Trial Results Presented at EHA 2026
4个月前
Ligand Pharmaceuticals Acquires XOMA Royalty for $739 Million, Expanding Portfolio to Over 200 Drug Assets
第 1 页,共 54 页
上一页
下一页